APA (7th ed.) Citation

Liu, B., Zhang, W., Huang, R., Liu, D., Liu, J., Han, A., . . . Chen, D. (2026). A Disproportionality Analysis of Immune Checkpoint Inhibitors in Combination With Platinum‐Based Agents Using the FDA Adverse Event Reporting System Database. Cancer Medicine, 15(4), 1. https://doi.org/10.1002/cam4.71527

Chicago Style (17th ed.) Citation

Liu, Boyi, Wenchao Zhang, Ruizhe Huang, Dinwen Liu, Jiaxing Liu, Ao Han, Yike Li, and Danna Chen. "A Disproportionality Analysis of Immune Checkpoint Inhibitors in Combination With Platinum‐Based Agents Using the FDA Adverse Event Reporting System Database." Cancer Medicine 15, no. 4 (2026): 1. https://doi.org/10.1002/cam4.71527.

MLA (9th ed.) Citation

Liu, Boyi, et al. "A Disproportionality Analysis of Immune Checkpoint Inhibitors in Combination With Platinum‐Based Agents Using the FDA Adverse Event Reporting System Database." Cancer Medicine, vol. 15, no. 4, 2026, p. 1, https://doi.org/10.1002/cam4.71527.